Free Trial

12 Cannabis Stocks to Buy Now - 5 of 12

 
 

Organigram (TSE:OGI)

MarketBeat Followers
1,203
Market Cap
C$277.94 million
Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
3 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
C$3.98 (55.3% Upside)

About Organigram

Organigram logoOrganigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/14/2024Canaccord Genuity GroupBoost Price TargetSpeculative BuyC$3.25 ➝ C$3.60
5/17/2024Jefferies Financial GroupLower Price TargetC$4.40 ➝ C$4.35
5/15/2024Canaccord Genuity GroupLower Price TargetSpeculative BuyC$3.75 ➝ C$3.25
4/3/2024ATB CapitalSet Price TargetOutperformC$5.25
2/27/2024Jefferies Financial GroupLower Price TargetBuyC$4.95 ➝ C$4.40
2/14/2024Alliance Global PartnersBoost Price TargetNeutralC$2.00 ➝ C$2.70
12/20/2023ATB CapitalBoost Price TargetOutperformC$5.50 ➝ C$6.50
12/20/2023Alliance Global PartnersLower Price TargetC$2.25 ➝ C$2.00
12/20/2023Canaccord Genuity GroupLower Price TargetC$4.00 ➝ C$3.75
7/18/2023Haywood SecuritiesLower Price TargetC$5.00 ➝ C$3.00
 

The Final Frontier (Ad)

And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.

Here’s the full story for you.